Michael P. Plant - 09 Nov 2026 Form 4 Insider Report for Atlanta Braves Holdings, Inc. (BATRK)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Nov 2026, 16:05:09 UTC
Prior SEC filing
15 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Greg Heller, Attorney-in-Fact
Filing notes and source

Key filing fact

Michael P. Plant filed Form 4 for Atlanta Braves Holdings, Inc. (BATRK) on 12 Nov 2026.

Key facts

  • This page summarizes Michael P. Plant's Form 4 filing for Atlanta Braves Holdings, Inc. (BATRK).
  • 10 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 15 Dec 2025.
  • Current net transaction value: -$9,661,252.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002036190 Primary reporting owner

Plant Michael P.

Relationship
EVP, Development
Address
C/O ATLANTA BRAVES HOLDINGS, INC., 755 BATTERY AVENUE SE, ATLANTA
Signature
/s/ Greg Heller, Attorney-in-Fact
Signature date
12 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BATRK transaction

Series C Common Stock

Options Exercise

Transaction value
Shares
+57,395
Change %
+21%
Price
$27.18*
Shares after
326,913
Date
09 Nov 2026
Ownership
Direct
Footnotes
F1
BATRK transaction

Series C Common Stock

Sale

Transaction value
-$2,943,216
Shares
-57,395
Change %
-18%
Price
$51.28
Shares after
269,518
Date
09 Nov 2026
Ownership
Direct
Footnotes
F2, F3
BATRK transaction

Series C Common Stock

Options Exercise

Transaction value
Shares
+57,000
Change %
+21%
Price
$27.18*
Shares after
326,518
Date
10 Nov 2026
Ownership
Direct
BATRK transaction

Series C Common Stock

Sale

Transaction value
-$2,975,970
Shares
-57,000
Change %
-17%
Price
$52.21
Shares after
285,903
Date
10 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F4
BATRK transaction

Series C Common Stock

Options Exercise

Transaction value
Shares
+57,000
Change %
+20%
Price
$27.18*
Shares after
342,903
Date
11 Nov 2026
Ownership
Direct
BATRK transaction

Series C Common Stock

Sale

Transaction value
-$2,952,030
Shares
-57,000
Change %
-17%
Price
$51.79
Shares after
285,903
Date
11 Nov 2026
Ownership
Direct
Footnotes
F2, F5
BATRK transaction

Series C Common Stock

Sale

Transaction value
-$790,036
Shares
-15,193
Change %
-100%
Price
$52.00
Shares after
0
Date
11 Nov 2026
Ownership
By Grantor Retained Annuity Trust
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BATRK transaction Derivative

Stock option (Right to Buy) - BATRK

Options Exercise

Transaction value
Shares
-57,395
Change %
-20%
Price
$0.000000*
Shares after
228,000
Date
09 Nov 2026
Ownership
Direct
Underlying class
Series C Common Stock
Underlying amount
57,395
Exercise price
$27.18
Footnotes
F2
BATRK transaction Derivative

Stock option (Right to Buy) - BATRK

Options Exercise

Transaction value
Shares
-57,000
Change %
-25%
Price
$0.000000*
Shares after
171,000
Date
10 Nov 2026
Ownership
Direct
Underlying class
Series C Common Stock
Underlying amount
57,000
Exercise price
$27.18
Footnotes
F2
BATRK transaction Derivative

Stock option (Right to Buy) - BATRK

Options Exercise

Transaction value
Shares
-57,000
Change %
-33%
Price
$0.000000*
Shares after
114,000
Date
11 Nov 2026
Ownership
Direct
Underlying class
Series C Common Stock
Underlying amount
57,000
Exercise price
$27.18
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Includes (i) 23,925 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to him in satisfaction of the GRAT's annuity obligation on December 7, 2023, that were inadvertently not reflected in the reporting person's previously reported holdings, and (ii) 16,385 shares of Series C Common Stock previously held indirectly by the reporting person through his GRAT and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation on November 10, 2026.

Footnote F2

The sales reported in this Form 4 and identified by this footnote were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 7, 2026.

Footnote F3

Reflects the weighted average sale price. The range of prices for such transaction is $50.43 to $52.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F4

Reflects the weighted average sale price. The range of prices for such transaction is $51.57 to $52.62. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F5

Reflects the weighted average sale price. The range of prices for such transaction is $51.36 to $52.13. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .